Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Data Validation01:15

Data Validation

579
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
579
Data Validation01:03

Data Validation

6.3K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.3K
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

601
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
601
Applications of Molecular Taxonomy01:20

Applications of Molecular Taxonomy

522
Molecular taxonomy has revolutionized the understanding and classification of bacteria, providing precise insights into their diversity, evolutionary relationships, and ecological roles. By utilizing molecular techniques such as DNA sequencing and fingerprinting, researchers have made significant strides in various fields related to bacterial studies.Resolving Taxonomic AmbiguitiesMolecular taxonomy has been instrumental in distinguishing closely related bacterial species initially thought to...
522

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I.

JCO precision oncology·2026
Same author

Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E.

JCO precision oncology·2026
Same author

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i><sup><i>V600E</i></sup> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H.

JCO precision oncology·2026
Same author

Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide Images.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Phase II Study of Vismodegib in Patients With <i>SMO-</i> or <i>PTCH1</i>-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T.

JCO precision oncology·2025
Same journal

Prohibited AI Practices in Healthcare under the European Artificial Intelligence Act.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2026
Same journal

Probing the Prevalence of Pharmaceutical Corruption.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2026
Same journal

Regulatory Guidance for the Return of Raw Genomic Data to Research Participants: A Qualitative Interview Study.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2026
Same journal

Supported Decision-Making and the Inclusion of People who Lack Decisional Capacity in Greater than Minimal Risk Research.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2026
Same journal

Using Supported Decision-Making to Promote Value-Aligned Research Participation.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2026
Same journal

Intellectual Disability and Supported Decision-Making in Clinical Research: Anticipating Ethical Challenges.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2026
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K

Biomarker Validation: Context and Complexities.

Lisa M McShane1

  • 1Lisa M. McShane, Ph.D., is with the Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute in Bethesda, MD.

The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|September 28, 2019
PubMed
Summary
This summary is machine-generated.

Validating biomarker tools requires tailored evidence to prove analytical and clinical performance. This ensures a favorable benefit-to-risk balance for medical product development.

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.2K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.2K

Related Experiment Videos

Last Updated: Jan 19, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.2K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.2K

Area of Science:

  • Biomarker discovery and validation
  • Medical product development
  • Clinical diagnostics

Background:

  • Biomarker-based tools are crucial for medical product development.
  • Rigorous validation is essential for clinical utility.
  • Tailoring validation to intended use is paramount.

Purpose of the Study:

  • To outline the evidentiary requirements for validating biomarker-based medical product development tools.
  • To emphasize the need for use-specific validation strategies.
  • To highlight the importance of demonstrating analytical and clinical performance.

Main Methods:

  • Review of validation principles for biomarker assays.
  • Analysis of data requirements for performance assessment.
  • Consideration of benefit:risk assessment frameworks.

Main Results:

  • Validation is an evidence-based process.
  • Performance criteria must align with the intended application.
  • Demonstrating analytical and clinical validity is key.

Conclusions:

  • Biomarker validation must be tailored to the specific use case.
  • Sufficient data are required to meet performance standards.
  • Favorable benefit:risk balance is the ultimate goal of validation.